Immunotherapy for Recurrent Cervical Cancer Refractory to Platinum-based Chemotherapy: Multi-Center Trial

Clinical trial NCT05290935 · UNKNOWN

Trial details

NCT number: NCT05290935
Sponsor: Lei Li
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent Cervical Carcinoma Persistent Advanced Cervical Carcinoma Chemotherapy Immune Checkpoint Inhibitors Anti-PD-1 Antibody Albumin-bound Paclitaxel

Start date: 2022-03-13
Primary completion: 2022-12-13
Enrollment: 122

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.